Addison Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Sell
273
-1,114
-80% -$1.14M 0.15% 87
2026
Q1
$1.28M Buy
1,387
+7
+0.5% +$7.1K 0.28% 73
2025
Q4
$1.48M Buy
1,380
+47
+4% +$44.9K 0.33% 63
2025
Q3
$1.02M Buy
1,333
+192
+17% +$143K 0.24% 77
2025
Q2
$889K Sell
1,141
-26
-2% -$20.2K 0.22% 79
2025
Q1
$964K Buy
1,167
+215
+23% +$179K 0.26% 67
2024
Q4
$735K Sell
952
-14
-1% -$11.6K 0.2% 80
2024
Q3
$856K Buy
966
+30
+3% +$27K 0.24% 75
2024
Q2
$847K Buy
936
+46
+5% +$36.8K 0.27% 69
2024
Q1
$692K Buy
890
+237
+36% +$169K 0.24% 78
2023
Q4
$381K Hold
653
0.15% 112
2023
Q3
$351K Buy
653
+3
+0.5% +$1.55K 0.16% 104
2023
Q2
$305K Hold
650
0.15% 115
2023
Q1
$223K Sell
650
-17
-3% -$5.73K 0.13% 129
2022
Q4
$244K Buy
667
+9
+1% +$3.19K 0.15% 113
2022
Q3
$213K Hold
658
0.13% 108
2022
Q2
$213K Buy
658
+1
+0.2% +$300 0.13% 119
2022
Q1
$188K Buy
657
+2
+0.3% +$515 0.1% 145
2021
Q4
$181K Buy
655
+5
+0.8% +$1.27K 0.11% 126
2021
Q3
$150K Hold
650
0.12% 101
2021
Q2
$149K Buy
+650
New +$131K 0.12% 103
2020
Q4
$110K Buy
+650
New +$97K 0.11% 118

Other funds holding LLY

Addison Advisors's LLY Position: Q2 2026 in Review

Addison Advisors reduced its Eli Lilly (LLY) stake by 80% in Q2 2026, selling an estimated $1.14M and leaving 273 shares worth $328K. The position accounts for 0.15% of the portfolio, ranked #87.

Addison Advisors first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.48M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Addison Advisors held 273 shares of Eli Lilly worth $328K as of Q2 2026.
  • Addison Advisors sold 1,114 Eli Lilly shares in Q2 2026, an estimated $1.14M.
  • Eli Lilly made up 0.15% of Addison Advisors's portfolio in Q2 2026, its #87 holding.
  • Addison Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Addison Advisors's Eli Lilly position peaked at $1.48M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.